These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26040525)

  • 1. Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock? Authors' reply.
    Karvellas CJ; Abraldes JG; Arabi Y; Kumar A;
    Aliment Pharmacol Ther; 2015 Jul; 42(1):123-4. PubMed ID: 26040525
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: what else can improve survival in cirrhotic patients with spontaneous bacterial peritonitis and associated septic shock?
    Chen PZ; Wang CC
    Aliment Pharmacol Ther; 2015 Jul; 42(1):123. PubMed ID: 26040524
    [No Abstract]   [Full Text] [Related]  

  • 3. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study.
    Karvellas CJ; Abraldes JG; Arabi YM; Kumar A;
    Aliment Pharmacol Ther; 2015 Apr; 41(8):747-57. PubMed ID: 25703246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of spontaneous bacterial peritonitis with oral ofloxacin: inpatient or outpatient therapy?
    García-Tsao G
    Gastroenterology; 1996 Oct; 111(4):1147-50. PubMed ID: 8831614
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention. Authors' reply.
    Dever JB; Sheikh MY
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1298. PubMed ID: 25968149
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of activated protein C in a case of paediatric septic shock.
    Verre M; Barozzi E; Piccirillo M; Tancioni F; Tiburzi S; Varano M
    Minerva Pediatr; 2005 Dec; 57(6):429-32. PubMed ID: 16402015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Leblanc M
    Clin Nephrol; 1997 May; 47(5):350. PubMed ID: 9181286
    [No Abstract]   [Full Text] [Related]  

  • 8. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of peritonitis within the scope septic shock with antibiotics].
    Eckert P; Eichen R; Schassan HH
    Chirurg; 1976 Jun; 47(6):318-21. PubMed ID: 782801
    [No Abstract]   [Full Text] [Related]  

  • 10. The authors reply.
    Rimmer E; Kumar A; Zarychanski R
    Crit Care Med; 2013 Jul; 41(7):e139-40. PubMed ID: 23774364
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies on administration of taurolin in severe sepsis: a preliminary study.
    McCartney AC; Browne MK
    Prog Clin Biol Res; 1988; 272():361-71. PubMed ID: 3293082
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous bacterial peritonitis: few additional points.
    Jain P
    World J Gastroenterol; 2009 Dec; 15(45):5754-5. PubMed ID: 19960577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Septic shock caused by Gardnerella vaginalis and Peptostreptococcus species after Cesarean section].
    Datcu R; Charib K; Kjaeldgaard P
    Ugeskr Laeger; 2009 Mar; 171(12):1012. PubMed ID: 19284925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Orlando F; Silvestri C; Bozzi A; Di Giulio A; Luzi C; Mangoni ML; Barra D; Saba V; Scalise G; Rinaldi AC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2478-86. PubMed ID: 16801429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.
    Kumar A
    Virulence; 2014 Jan; 5(1):80-97. PubMed ID: 24184742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B haemoperfusion in septic shock patients.
    Shime N; MacLaren G
    Intensive Care Med; 2015 Nov; 41(11):2033. PubMed ID: 26179431
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymyxin B hemoperfusion in septic shock: just look at the evidence!
    Antonelli M; Cutuli SL; Ronco C
    Intensive Care Med; 2015 Sep; 41(9):1731-2. PubMed ID: 26197847
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibacterial therapy in the complex treatment of a disseminated form of peritonitis, complicated by infectious-toxic shock].
    Savel'ev VS; Gologorskiĭ VA; Gel'fand BR; Filimonov MI; Bekbergenov BM
    Antibiot Khimioter; 1989 Feb; 34(2):143-7. PubMed ID: 2730227
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and treatment of uncomplicated and complicated surgical infections.
    Surgery; 2000 Oct; 128(4 Suppl):S19-30. PubMed ID: 11022168
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.